Researchers showed that ERp29 was a novel target for microRNA-135a-5p to inhibit the progression of colorectal cancer (CRC); correspondingly, ERp29 acted as an oncoprotein in CRC by promoting proliferation and metastasis of CRC cells, and suppressing apoptosis of the cells.
[Cell Death & Disease]
Sorry, but the selected Zotpress account can't be found.
